PSC-833 (valspodar)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PSC-833 (valspodar), covering 2012-11-30 to 2012-11-30. Get the full timeline:
Most recent: Clinical Trial Update: Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia [Phase 1, Phase 2]